HEALTHCARE
HUMAN INSULIN MARKET
FORECASTS TO 2020
REPORT CODE BT 3981
HUMAN INSULIN MARKET- FORECASTS TO 2020
Drugs( Biologics, Biosimilars), Type( Short Acting, Long Acting, Premixed), Brands( Lantus, Novorapid, Humalog), Delivery Devices( Pens, Pen Needles, Syringes), Applications( Type 1 Diabetes, Type 2 Diabetes)
REPORT OVERVIEW
1.1 OBJECTIVES OF THE STUDY
• To define, describe, and forecast the global human insulin market on the basis of product, human insulin drugs type, human insulin drugs brand, delivery device, and application
• To provide detailed information regarding major factors influencing growth of the market( drivers, restraints, opportunities, and challenges)
• To strategically analyze micromarkets with respect to individual growth trends, future prospects, and contributions to the overall market
• To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for leading market players
• To forecast the size of the market segments with respect to four main regions, namely, North America( U. S. and Canada), Europe( Germany, France, U. K., and Rest of Europe), Asia-Pacific( Japan, China, India, and Rest of Asia-Pacific), and the Rest of the World
• To strategically profile the key market players and comprehensively analyze their market shares and core competencies
• To track and analyze competitive developments such as joint ventures; mergers and acquisitions; new product developments; and partnerships, agreements, and collaborations in the human insulin market
sales @ marketsandmarkets. com www. marketsandmarkets. com
1